The role of stress in absenteeism: Cortisol responsiveness among patients on long-term sick leave. by Jacobsen, Henrik Børsting et al.
The Role of Stress in Absenteeism: Cortisol
Responsiveness among Patients on Long-Term Sick
Leave
Henrik B. Jacobsen1,2,3*, Johan Ha˚kon Bjørngaard4,5, Karen W. Hara1,2,3, Petter C. Borchgrevink1,2,3,
Astrid Woodhouse2,3,4, Nils Inge Landrø3,6, Anette Harris7, Tore C. Stiles2,3,8
1Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, Trondheim, Norway, 2Hysnes Rehabilitation Center, St. Olav’s
University Hospital, Trondheim, Norway, 3National Centre for Complex Disorders, St. Olav’s University Hospital, Trondheim, Norway, 4Department of Public Health and
General Practice, Norwegian University of Science and Technology, Trondheim, Norway, 5 Forensic Department and Research Centre Brøset, St. Olav’s University Hospital,
Trondheim, Norway, 6Clinical Neuroscience Research Group, Department of Psychology, University of Oslo, Oslo, Norway, 7Department of Health Promotion and
Development, Faculty of Psychology, University of Bergen, Bergen, Norway, 8Department of Psychology, Norwegian University of Science and Technology, Trondheim,
Norway
Abstract
Objective: This study aimed to (1) See whether increased or decreased variation relate to subjective reports of common
somatic and psychological symptoms for a population on long-term sick leave; and (2) See if this pattern in variation is
correlated with autonomic activation and psychological appraisal.
Methods: Our participants (n = 87) were referred to a 3.5-week return-to-work rehabilitation program, and had been on paid
sick leave .8 weeks due to musculoskeletal pain, fatigue and/or common mental disorders. An extensive survey was
completed, addressing socio-demographics, somatic and psychological complaints. In addition, a physician and a
psychologist examined the participants, determining baseline heart rate, medication use and SCID-I diagnoses. During the
3.5-week program, the participants completed the Trier Social Stress Test for Groups. Participants wore heart rate monitors
and filled out Visual Analogue Scales during the TSST-G.
Results: Our participants presented a low cortisol variation, with mixed model analyses showing a maximal increase in free
saliva cortisol of 26% (95% CI, 0.21–0.32). Simultaneously, the increase in heart rate and Visual Analogue Scales was
substantial, indicating autonomic and psychological activation consistent with intense stress from the Trier Social Stress Test
for Groups.
Conclusions: The current findings are the first description of a blunted cortisol response in a heterogeneous group of
patients on long-term sick leave. The results suggest lack of cortisol reactivity as a possible biological link involved in the
pathway between stress, sustained activation and long-term sick leave.
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Introduction
The majority of long-term sick leave is explained with
musculoskeletal pain and mental disorders where stress manage-
ment and job strain might play an important role [1]. The
hypothalamus-pituitary-adrenal (HPA) axis and its end product,
cortisol, has been linked to chronic pain, chronic fatigue, anxiety
and depression [2–5]. These four symptoms often justify long-term
sick absence and decrease the individuals’ quality of life [1,6].
Stress however, either in the form of job strain or other negative
psychosocial experiences, is a widely debated concept with
numerous definitions [7]. A recent systematic review argues that
a strict definition is needed, and that only a physiological definition
of stress characterized by neuroendocrine reactions can provide
this [7]. Incorporating appraisal and experience, Koolhaas et al.,
[7] argue that pathological stress occurs only when the individuals’
demands exceed their normal regulatory capacity over time. This
is marked by the lack of an anticipatory neuroendocrine response
and/or a reduced neuroendocrine recovery [7]. This definition is
supported by accumulated data from human studies demonstrat-
ing how persistent physiological stress affect the feedback
mechanisms of the HPA-axis [8].
A recurring problem with cortisol studies is that the findings are
somewhat contradictory, often showing both hypo and hyper
activation of the HPA-axis [2,8]. Along with the aforementioned
review, several studies have suggested that contradictory results are
related to sustained activation of the HPA-axis over time, yielding
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different phases of dysregulation [7,9]. This would entail that
dysregulation can create both a hypo- or hyper expression of
cortisol in the same phenotype, the common factor being a lack of
variability and/or reactivity in the hormonal expression [3,8,10].
Low variability in cortisol release combined with reduced
habituation has been suggested as a direct physiological expression
of vital exhaustion, a mental state in which the catabolic capacity
for stress adaptation is disrupted [10–12]. This hypothesis has
received support from several studies using a standardized
psychosocial stress procedure known as the Trier social stress test
[3,13]. In healthy participants, the Trier test has been adminis-
trated more than 4000 times and is consistently shown to predict
stress in the form of saliva cortisol increase [13,14]. A meta-
analysis of 48 Trier test studies on healthy participants showed a
large mean cortisol effect size of 0.92 (95% confidence interval (CI)
0.70, 1.14) and this effect proved highly significant (p,0.001).
Almost the same effect size was observed for recovery after the
stressor had been completed, describing almost an inverted U
relationship (d=0.85, 95% CI 0.63, 1.07, p,.01) [15].
With cortisol being a metabolic hormone with the critical
function of mobilizing energy and reducing inflammation, one
suggested pathway or mechanism could be that sustained
physiological stress activation may be causally related to fatigue,
musculoskeletal pain, depression, and anxiety through this lack of
variability [12].
Describing evidence for such a pathway more specifically,
several studies show a link between life stress, hyper vigilance and
development of fibromyalgia [16]. This is supported by results
showing that altered HPA-activity is strongly associated with both
regional and widespread pain [4]. Depressive symptoms are linked
to life stress to such an extent that a causal relationship has been
suggested [17]. A potential mechanism explaining this link has
been demonstrated through reduced glucocorticoid receptor
sensitivity modulated by a polymorphic expression of the FKBP5
gene [18]. This is also demonstrated in longitudinal studies of
cortisol secretion, where low variation in diurnal cortisol release
has been linked with depression [19], and depressed patients
demonstrate both hyper- and hypo-activation of the HPA-axis [5].
Similar findings are reported in a range of anxiety disorders
[15,18], where a low variability of cortisol expression in response
to the Trier social stress test in patients with panic disorder, is
perhaps the most striking finding [3]. In chronic fatigue syndrome,
stress has been shown to exacerbate the symptoms of fatigue [20],
and these patients also demonstrate blunted responses to a
standardized psychosocial stressor [21].
The contradiction of having both hypo- and hypercorticolism
findings is often highlighted and possibly caused by numerous
confounding variables, like differences in methods and/or
population characteristics [8,22]. It has been suggested that for
disorders like pain and fatigue, one of the most important
confounding factors is psychiatric comorbidity [23]. The current
study specifically addresses psychiatric disorders and confounding
variables by providing an extensive somatic, psychological and
social screening.
Combining basic research in endocrinology, psychology and
clinical studies, we wanted to utilize the knowledge about such
pathways to better understand the major causes of disability and
investigate potential common factors. The aims of this study are: 1)
when controlling for socio-demographics, to use a standardized
stressor to see whether increased or decreased cortisol variation is
related to SCID-diagnoses, current medication and/or subjective
reports of somatic and psychological symptoms in a population on
long-term sick leave; and 2) to see if this pattern in variation is
related to autonomic activation and/or psychological appraisal.
We hypothesize that our participants will display a reduced
variation in cortisol secretion when responding to a standardized
psychosocial stress test, regardless of their self-reported symptom
load and autonomic activation.
Materials and Methods
Ethics statement
All participants signed an informed consent outlining the study
before inclusion.
The study was approved by the Regional Committee for
medical and health research ethics, Central Norway and
conducted in accordance with the Declaration of Helsinki.
Study participants
This was a repeated measures study with participants being
consecutively recruited from a clinical setting throughout 2012.
General practitioners (GP) referred patients between 18–59 years
of age to a 3.5-week in-patient intervention at Hysnes Rehabil-
itation Center, Norway. The patients had been on sick leave
longer than 8 weeks due to musculoskeletal pain, fatigue and/or
common mental disorders. Prior to the intervention, the partic-
ipants filled out an extensive web-based survey provided by
CheckWare. This survey included measures of socio-demograph-
ics, pain, fatigue, mental distress and sleep problems. Participants
also met with a physician and a psychologist for psychological and
physical examinations. Upon admission, the participants were
asked to participate in a study while receiving the intervention. A
total of 194 patients were included in a main study investigating
the effects of rehabilitation. From this population, 87 patients were
selected via list randomization to participate in a stress study. The
stress study involved participating in standardized stress tests pre-
and post-intervention.
Participants were excluded only if they had acute psychosis,
ongoing manic episode or suicidal ideation, were not able to
communicate in Norwegian, or if they were pregnant. Also, this
being return-to-work rehabilitation, participants were excluded if
did not define return to work as a personal goal. Of the 87
participants in the stress study, 3 participants were coded as
missing because of missing values on the key variable cortisol,
leaving the final n at 84 participants.
Standardized stress procedure
To create acute psychosocial stress we used the Trier Social
Stress Test for Groups [24]. This protocol has repeatedly
demonstrated the ability to elicit a significant stress response in
healthy participants [24,25]. This test deviates from the original
Trier Social Stress Test on actual exposure time (2 versus 5 or 10
minutes), but has been validated against the Trier Social Stress
Test in several studies [24,25].
The Trier Social Stress Test for Group (TSST-G) consists of a
mock job interview and mental arithmetic performed in front of a
group of peers and an experimenter panel. Each session lasts
approximately 2,5 h, including a 60-minute preparation phase, a 20-
minute exposure phase and a 60-minute recovery phase. Each test
includes 7 measure-points of saliva cortisol collected by the
research personnel pertaining to the timeline illustrated in figure 1.
All TSST-G exposures were conducted at one of two time slots,
either 1630 h to 1900 h or 1300 h to 1530 h. These time slots
have been statisticly validated through rigouros studies [26].
In the preparation phase, the participants were told to relax and
avoid any strenuous activity. Ten minutes before the preparation
phase was over the participants were told to prepare for a job
interview, and filled out three Visual Analog Scales (VAS). Afterwards
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the participants entered the exposure phase, where each participant
was given a number so that they could be identified during the
experiment. Mobile walls were used to separate the participants,
and they received no feedback other than the standardized
instructions from a designated spokesperson in the test panel. The
exposure phase was initiated with a two-minute random exposure
through the public speaking task/job interview and after all
participants had performed the interview, and taken a second
saliva sample, a mental arithmetic task was introduced. Each
participant was then randomly selected to do arithmetics for 1.5
minutes as part of the exposure phase. After completion of the
arithmetics the test moved over in the debriefing phase, where the
participants were given the opportunity to share thoughts and
reflections about their experience. A saliva sample was taken every
15 minutes of the debriefing period (in total 4 salivettes) to monitor
recovery. An overview of the entire experimental session with
sampling is illustrated in figure 1, and further details about the
experimental protocol are available in the appendix S1.
Endocrine stress responses
The sampling of saliva cortisol followed earlier protocols
studying cortisol responses to acute stress [24]. The saliva samples
were collected with purpose-designed polyester salivettes (Sarstedt
Inc., Rommelsdorf, Germany), which has been used in several
previous studies [24,27]. After sampling, the salivettes were
immediately frozen at 220 uC.
For analyses, at the Department of Medical Biochemistry at St.
Olav’s Hospital, Trondheim, the samples were thawed, centri-
fuged and analyzed on Modular E170 from Roche using an
electrochemiluminescens immunoassay (ECLIA) method. Modu-
lar E 170 is a fully automatic analysis module for immunochemical
assays. The assay used for determination of cortisol in saliva had
an interassay variability of 7.9% at 12 nmol/L.
Autonomic stress responses
Continuous recording of heart rates was used both as a measure
of task engagement and sympathetic arousal. This study used a
wireless chest heart rate transmitter and a wristwatch recorder
(Polar RS800TM, Polar Electro, Finland). A trained physician
assessed a baseline recording of heart rate during the examination
at Hysnes outpatient clinic. The subjects were standing in an
upright position during the baseline recording and all through the
exposure phase of the TSST-G.
Self-reported somatic and psychological symptoms
Chronic fatigue was measured with the Chalder Fatigue Ques-
tionnaire [28] that consists of eleven questions assessing physical
and mental fatigue. The scale was later revised to include two
items pertaining to extent and duration [29]. Each item has four
response categories scored bimodally 0-0-1-1. The 11 first items
are summed and yield a scale of 0–11. This thirteen-item scale has
been validated for a Norwegian population, and has a cut-off on
symptom intensity $5, lasting for 6 months or more [29].
The Hospital Anxiety and Depression Scale (HADS) [30]
assesses symptoms of anxiety and depression. The fourteen-item scale
with each item ranging from 0–3 yields separate scores for anxiety
and depression, which are summed. A score $8 on either subscale
was used to indicate caseness. This cut-off is validated for a
Norwegian population [31].
Chronic pain was measured with an item from Short Form-8 [32]
asking ‘‘How much bodily pain have you had the last week?
(None, very mild, mild, moderate, severe, very severe)’’. This scale
has been validated as a self-report measure of chronic pain in
Norwegian population studies, using the cut-off $moderate [33].
The Insomnia Severity Index [34] (ISI) is a seven-item
questionnaire assessing sleep problems. A 5-point (0-4) scale, rated
difficulties falling asleep, night-time awakenings, early morning
awakenings, impairment of daytime functioning due to sleep
problems, notice ability of impairments, distress or worry caused
by sleep difficulties, and dissatisfaction with sleep. The items were
summed; giving a scale of 0–28, where $15 was used as a cut-off
indicating caseness. This cut-off has been validated in previous
studies [35].
The participant’s age, gender, height, weight, relationship status, and
education were reported through a standardized set of questions
described elsewhere [36].
The participants filled out Visual Analog Scales (VAS) 10 minutes
before, and 3 times during, the exposure phase of TSST-G, as done
in previous studies [24]. These scales held one question each with
a range 0–100, 0 being ‘‘not at all’’, and a 100 being ‘‘the most
Figure 1. Overview of the exposure session showing collection of saliva samples, VAS scales and heart rate monitoring.
doi:10.1371/journal.pone.0096048.g001
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intense experience tolerable’’. The statements pertained to
avoidance ‘‘To what extent do you want to leave this setting?’’
Anxiety: ‘‘To what extent do you feel uncomfortable in this
setting?’’ And tension: ‘‘To what extent do you feel tension in your
body right now?’’ VAS scales are considered a valid and feasible
measure of clinical phenomena in an experimental setting [37].
Psychological and medical examination
Using the Structured Clinical Interview for DSM-IV [38]
(SCID-I), a clinical psychologist screened participants for the 13
most common psychiatric disorders. Using criteria from DSM-IV,
the diagnoses ranged from depression to panic disorder. In brief,
the following diagnoses were present: Major Depression (6 cases),
Recurrent Depression (3 cases), Dysthymia (2 cases), Panic
Disorder (2 cases), Anxiety (3 cases) and Post Traumatic Stress
Disorder (1 case).
A physician reviewed the participants’ medical records and
assessed current medication and smoking, adding this to the
research database. Current smoker was defined as having one or
more cigarettes the last 7 days, current medication was defined as a
valid prescription at the time of examination. Antidepressants and
synthetic hormones were included as potential confounders based
on a review investigating medications affecting saliva cortisol
secretion [39].
Statistical analyses
Free saliva cortisol values in the TSST-G were modeled by
repeated measures using the natural log transformation of cortisol
and fitting random effects models with random slopes [40]. The
results were transformed back to yield values in nmol/l. The
participant’s sex, age and BMI were fixed on average levels to
represent mean values for this population. Autonomic activation
was analyzed through a paired t-test comparing average heart rate
during an examination at the outpatient clinic with heart rate
during the TSST-G exposure. Scores on Visual Analogue Scales
were modeled for repeated measures and we used random effects
models fitted with random slopes as with the saliva cortisol
measures.
All results are reported with a coefficient and/or average values
with 95% confidence intervals (CI). All analyses were carried out




The participants (N= 84) were 71.4% women with a mean age
of 41.5 years (SD, 10.0 years). The majority was married or living
with a partner (71%) and had some college or university education
(54.9%). Seventy-nine percent of our participants reported fatigue
lasting more than 6 months, 75% reported chronic pain, 54%
reported depression, 61% reported anxiety and 46% reported
more than 3 symptoms above the clinical cut-off (Table 1).
The participants in this study presented a low cortisol variation
in response to the TSST-G. Our participants showed a 26% (95%
CI, 0.21–0.32) higher cortisol level at the 4th time point, when
compared with the first (Table 2). Investigating recovery, our
participants did not show any substantial recovery during the
exposure phase or the rest and debrief phase (2.06%, 95% CI,
20.12–.004) (Figure 2).
In figure 3, TSST-G curves from participants were dichoto-
mized as ‘‘Yes’’ or ‘‘No’’ based on established cut-offs (fatigue,
pain, anxiety, depression and/or sleep problems) or occurrence/
non-occurrence (smoking, SCID-diagnosis and/or medication).
There was weak evidence for any statistical interaction between
the exposure effect on cortisol response and self-reported caseness
of chronic fatigue, depression, anxiety, chronic pain, sleep
problems, antidepressant/synthetic hormone medication, one or
more SCID Axis-I diagnoses, age, sex or BMI (p.0.05). There
was evidence of statistical interaction between the exposure effect
on cortisol response and smoking (p= 0.003). There was a
tendency towards a higher initial cortisol level and a weaker
exposure effect in smokers (Figure 3).
Heart rate stress responses
Our participants demonstrated an averaged increase of
41.2 beats/min (95% CI, 36.8–45.5) from the baseline measure
to the TSST-G exposure phase. This reflects a significant
autonomic activation when comparing a control measure done
by a physician with the 20 minutes of exposure in the TSST-G.
Psychological stress responses
In accordance with the autonomic responses, but in contrast to
the saliva cortisol responses, our participants indicated a stressful
appraisal of the TSST-G exposure phase. Our participants rated
their experience during the experiment on visual analog scales,
using a scale of 0–100. The averaged rating of avoidance increased
from 26.7 points (95%CI, 22.3–33.1) pre-exposure, to 55.4 points
(95%CI, 48.9–63) during exposure. The rating of anxiety
increased from 30.4 points (95%CI, 24.1–36.8) to 61.2 points
(95%CI, 54.7–67.8) and tension increased from 43.3 points
(95%CI, 37–49.6) to 68.1 points (95%CI, 55.6–67.3) (Figure 4).
Discussion
This is the first description of a possibly blunted cortisol
response in a heterogeneous group of patients on long-term sick
leave. Our participants were exposed to a well-established,
standardized psychosocial stressor, but failed to mount an
adequate neuroendocrinological response (maximal difference of
26,7%). In contrast to this, their assessment of the Trier Social
Stress Test for Groups (TSST-G) on VAS scales indicated that
they in fact were stressed by the experiment, and heart-rate
monitors showed a significant sympathetic activation collaborating
this. Further, the participants did not show any marked
neuroendocrinological recovery when measured for 60 minutes
after ending the TSST-G.
The lack of variability in the cortisol response was not explained
by reported use of medication, self-reported sleep problems,
chronic fatigue, chronic pain, anxiety, depression, nor the
presence of one or several SCID-I diagnoses. The only variable
that had any effect on variation was being a current smoker, which
is in line with studies showing habitual smokers have a decreased
cortisol responsiveness to psychosocial stress [39]. However, the
smokers only demonstrated an even more blunted response. The
increase of free saliva cortisol expected from the TSST-G was not
present in any of our participants.
Four main arguments increase the validity of our current results.
First, the Trier test is well documented and causes a 200–500%
cortisol increase in 75–85% of all participants [13,24]. Second,
rigidly designed studies have shown the measurement of adreno-
cortical activity through cortisol to be highly predictive of
psychosocial stress [41]. Third, a recent review concluded that
saliva cortisol is a reliable and valid measure of the biologically
active component of cortisol [39]. Fourth, a lasting dysregulation
of the HPA-axis would have several negative health consequences,
perhaps the most prominent being a feeling of fatigue [2].
Cortisol Reactivity in Absenteeism
PLOS ONE | www.plosone.org 4 May 2014 | Volume 9 | Issue 5 | e96048
Our population consists of heterogeneous participants on long-
term sick leave, referred to vocational rehabilitation, which is
interesting when we interpret the current results. In Norway we
have seen a 69% rise in people on long-term sick leave due to
exhaustion/fatigue in the last 12 years [42]. Several studies have
tied a dysregulation of the HPA-axis and a blunted response to
standardized stressors to self-reported feelings of fatigue and
exhaustion [8]. As the main function of cortisol is to prepare
peripheral organs for action through increasing metabolism and
releasing energy, the observed lack of cortisol responses may be a
key factor to explain the high prevalence of fatigue in the
population on long-term sick leave.
Seventy-nine percent of our participants reported clinically
significant mental and physical fatigue lasting for more than 6
months. Seeing HPA-axis dysregulation as a common factor in
patients on sick leave, manifesting through decreased energy and
fatigue is in line with studies looking at these symptom-categories
independently. However, observing the same effect, or lack there-
of, in a group with different diagnoses and medical history is a
cause for discussion. Kristenson et al. [12] outlined prolonged
activation as causing lack of cortisol response and reactivity in
their theoretical review of socioeconomic health differences. They
theorized that successful coping leads to adequate responses,
followed by relaxation and reduced activation. Lack of coping,
helplessness, and/or hopelessness over time will lead to sustained
activation and inability to recover. This state of prolonged
activation would have several negative health effects, such as
insulin resistance, persistent inflammation, infections and poor
lifestyle choices [12].
When interpreting these results, it could indeed be argued that
the TSST-G could have failed to cause stress in our participants.
However, when comparing results with a TSST-G study on
healthy participants using identical VAS-scales, our participants
reported twice as much increase on anxiety, tension and avoidance
from pre-exposure to exposure [24]. HPA-axis activity has been
linked specifically to such ego-threatening psychosocial stress [43],
and VAS scales are considered the gold standard when measuring
psychosocial stress during exposure [37]. The procedure for
TSST-G is adamant on the participant choosing a job they really
want for the interview, as to ensure task engagement. It is likely
that the engagement is even stronger in our population because
they are selected with a personal goal of returning to work. The
results from VAS-scales corroborate this.
Popular stress theories emphasize the concept of coping
expectancy, and how this is crucial when regulating physiology
in an effective and adequate manner [11]. It is tempting to
speculate whether this could explain the observed results. The job-
application part of the TSST-G would entail some of them
preparing for an interview for a similar job as the one they would
actually apply to in real life. Recent years have seen a development
in how we understand transitions between work and benefits.
Investigating a similar population to ours, Øyeflaten et al. [44]
showed that during a 4-year follow-up, the average number of
transitions was 3.7 (range 0–18) in a population on long-term sick
leave. Falling in-and-out of work four times in four years would
involve several negative coping experiences and likely affect
patients’ outcome expectancy.
Table 1. Characteristics of participants (n = 84) included in the Trier Social Stress Test for Groups.
Demographics Male Female
Gender (n) 28.6% (24) 71.4% (60)
Age (SD) 41.0 (11.8) 41.1 (9.2)
Body Mass Index (SD) 27.3 (4.6) 26.7 (6.8)
Married/Living with Partner (n) 68.2% (15) 71.7% (43)
Single/Divorced/Widowed (n) 31.8% (7) 28.3% (17)
Education (n):
Less than High School 18.2% (4) 11.9% (7)
High School 22.7% (5) 35.6% (21)
Some College/University 54.5% (12) 35.6% (21)
Any College/University Degree 4.5% (1) 16.9% (10)
Medication*(n):
Synthetic Thyroid Hormone 0 20% (12)
Antidepressants/Beta Blockers 13.6% (3) 6.6% (4)
Current Smoker (n) 40.9% (9) 10.3% (6)
SCID-I Diagnoses (n) 21% (5) 20% (12)
Self-reported Caseness Male Female
Depression (n) 54.5% (12) 53.3% (32)
Anxiety (n) 54.5% (12) 67.7% (40)
Chronic Fatigue (n) 77.3% (17) 76.6% (46)
Chronic Pain (n) 72.7% (16) 78.3% (47)
Sleep Problems (n) 31.8% (7) 45.8% (27)
More than 3 symptoms above cut-off 45,8% (11) 45,8% (27)
Categorical characteristics are reported as percent (frequency) and ordinal characteristics as mean (standard deviation).
*Of these participants, some received more than one of the three medications listed. Numbers may not add up to 84 because of missing data on some characteristics
doi:10.1371/journal.pone.0096048.t001
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Limitations
Our results show an interesting psychoneuroendocrinological
feature in participants on long-term sick leave. However, this study
also has limitations. The foremost being the lack of matched
healthy controls. Without a control group being subjected to
exactly the same experimental procedure, in exactly the same
location, we cannot make clear cut inferences about differences to
a normal population. However, this study does not compare actual
nmol/l values with previous studies, but rather high-low differ-
ences by percentages as measure of variability. The ability to
respond and recover measured through cortisol is the factor of
Figure 2. Cortisol responses to a standardized psychosocial stress test (TSST-G) in participants on long-term sick leave attending
Hysnes Rehabilitation Center (n =84) and healthy subjects (n =34) adapted from von Dawans et al [24] (licensed reuse by Elsevier,
license number: 3175410277640) exposed to identical experimental procedures (TSST-G). The gray bar represents the TSST-G exposure
phase, and error bars represent 95% confidence intervals.
doi:10.1371/journal.pone.0096048.g002
Table 2. Averaged variation of saliva cortisol compared measure point 1 with sex, BMI and age fixed at averaged levels for this
population.
Measure Point Coefficient 95%, CI
1 Comparison
2 0.16 0.11 0.21
3 0.24 0.19 0.29
4 0.27 0.21 0.32
5 0.13 0.08 0.19
6 0.05 20.008 0.11
7 20.06 20.13 0.004
Coefficients represent % rise or fall compared with the initial value at the start of exposure to TSST-G.
doi:10.1371/journal.pone.0096048.t002
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interest in stress theories, making a comparison by percentage of
variation highly relevant.
It could also be considered a limitation that this study uses the
short, group version of the TSST, rather than the ‘‘full’’ TSST.
However, the protocol and administration of the Trier test in a
group setting is thoroughly validated through several studies
[24,25]. A third limitation is the high percentage of women in this
study. There are clear differences in how cortisol is regulated in
men and women, and adult women usually show lower cortisol
and sympathetic responses than men of the same age [43]. We
found no statistical differences though, when participants were
tested for sex and saliva cortisol variability, indicating no specific
sex bias.
Moreover, we do not have complete control of all the social
factors influencing the experimental session. For instance, a group
dynamic would have formed in the preparation phase, possibly
influencing the outcome without our knowledge. Finally, the
studies listed in the discussion as comparison [24] have discrep-
ancies with regard to culture, gender distribution and socioeco-
nomic differences.
Concluding remarks
Despite these limitations, our participants’ rather specific failure
to respond adequately to a stress experiment suggests a lack of
cortisol reactivity as a biomarker of the pathway between sustained
activation and sick leave. Previous studies have speculated as to
whether a population on sick leave would have such pronounced
effects [10]. Genetic studies have also suggested a biological
disadvantage in catabolic stress responses for patients struggling
with anxiety and depression [18].
This is the first study to suggest a lack of cortisol reactivity in
patients on long-term sick leave and by doing so also supports
highly cited appraisal theories of stress. Future studies should
utilize a similar approach to investigate treatment effects on
patients on long-term sick leave, including a control group, and
possibly use genetic markers as to assess biological vulnerability.
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Figure 3. Fitted random effects models of subgroup analyses on participant characteristics. Characteristics were dichotomized as ‘‘Yes’’
or ‘‘No’’ based on established cut-offs (fatigue, pain, anxiety, depression and/or sleep problems) or occurrence/non-occurrence (smoking, SCID-
diagnosis and/or medication). The gray bar represents the TSST-G exposure phase, and error bars represent 95% confidence intervals.
doi:10.1371/journal.pone.0096048.g003
Figure 4. Visual analogue scales (VAS) completed before and during the TSST-G. The scales ranged from 0–100, and participants were told
that 0 was no feeling of discomfort and 100 represented the worst feeling of avoidance: ‘‘To what extent do you want to leave this setting?’’ Anxiety:
‘‘To what extent do you feel uncomfortable in this setting?’’ And tension: ‘‘To what extent do you feel tension in your body right now?’’ Error bars
represent 95% confidence intervals.
doi:10.1371/journal.pone.0096048.g004
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